Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.26 USD | +2.55% | +1.54% | +1.42% |
03-07 | Transcript : Phathom Pharmaceuticals, Inc., Q4 2023 Earnings Call, Mar 07, 2024 | |
03-07 | Phathom Pharmaceuticals, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
Evolution of the average Target Price on Phathom Pharmaceuticals, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Phathom Pharmaceuticals, Inc.
Needham & Co. | |
Goldman Sachs | |
HC Wainwright | |
Craig-Hallum | |
BMO Capital | |
Guggenheim | |
Jefferies & Co. |
EPS Revisions
- Stock Market
- Equities
- PHAT Stock
- Consensus Phathom Pharmaceuticals, Inc.